Cargando…
Comment on “Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma”
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431329/ https://www.ncbi.nlm.nih.gov/pubmed/37600880 http://dx.doi.org/10.1097/AS9.0000000000000254 |
_version_ | 1785091175130071040 |
---|---|
author | Qian, Xinye |
author_facet | Qian, Xinye |
author_sort | Qian, Xinye |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10431329 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Wolters Kluwer Health, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104313292023-08-18 Comment on “Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma” Qian, Xinye Ann Surg Open Letter to the Editor Wolters Kluwer Health, Inc. 2023-01-30 /pmc/articles/PMC10431329/ /pubmed/37600880 http://dx.doi.org/10.1097/AS9.0000000000000254 Text en Copyright © 2023 The Author(s). The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Letter to the Editor Qian, Xinye Comment on “Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma” |
title | Comment on “Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma” |
title_full | Comment on “Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma” |
title_fullStr | Comment on “Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma” |
title_full_unstemmed | Comment on “Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma” |
title_short | Comment on “Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma” |
title_sort | comment on “hepatectomy versus sorafenib in advanced nonmetastatic hepatocellular carcinoma” |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431329/ https://www.ncbi.nlm.nih.gov/pubmed/37600880 http://dx.doi.org/10.1097/AS9.0000000000000254 |
work_keys_str_mv | AT qianxinye commentonhepatectomyversussorafenibinadvancednonmetastatichepatocellularcarcinoma |